Related Experiment Video
Updated: Jun 22, 2026
10:51
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
Published on: January 5, 2021
Hypoxic tumor microenvironment and cancer cell differentiation
Yuri Kim1, Qun Lin, Peter M Glazer
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040, USA.
Current Molecular Medicine
|June 13, 2009
Summary
Hypoxia, or oxygen deficiency, promotes cancer stem cell maintenance by inhibiting tumor cell and stromal cell differentiation. Targeting these hypoxic cancer stem cells is crucial for effective tumor control.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Hypoxia (oxygen deficiency) is common in solid tumors.
- Hypoxic tumors are linked to malignancy, poor differentiation, and therapy resistance.
- Hypoxia may inhibit differentiation of both tumor and stromal cells.
Purpose of the Study:
- To explore the role of hypoxia in tumor progression and cancer stem cell maintenance.
- To investigate how hypoxia impacts tumor cell and stromal cell differentiation.
- To propose a paradigm for hypoxia's role in shaping the tumor microenvironment.
Main Methods:
- Review of existing evidence on hypoxia and cell differentiation in tumors.
- Analysis of the correlation between tumor hypoxia and malignancy.
- Hypothesis formulation based on observed cellular behaviors.
Main Results:
- Hypoxia inhibits differentiation of tumor cells, potentially maintaining cancer stem cells.
- Hypoxia also blocks differentiation of mesenchymal stem/progenitor cells, affecting stromal components.
- A hypoxic microenvironment may favor poorly differentiated tumor and stromal cells.
Conclusions:
- Hypoxia profoundly impacts the tumor stromal microenvironment.
- An undifferentiated, hypoxic microenvironment supports cancer stem cell maintenance.
- Targeting hypoxic cancer stem cells is a key strategy for tumor control.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...